Granted Patent
B2
US 8,580,786 · App. 12/971,786 · Granted Nov 12, 2013
Triazine derivatives and their therapeutical applications
Inventors:
Neil P. Desai (Los Angeles, CA); Patrick Soon-Shiong (Los Angeles, CA); Chunlin Tao (Los Angeles, CA); Qinwei Wang (Alhambra, CA)
Assignee:
Nant Holdings IP, LLC
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention provides for Triazine derivatives and their use to modulate protein kinase activity in a variety of conditions and diseases.
Claims (3)
1. A method for treating rheumatoid arthritis in a mammal comprising
(a) identifying the mammal afflicted with rheumatoid arthritis, and
(b) administering to said afflicted mammal a therapeutically effective amount of a composition comprising a compound or pharmaceutically acceptable form thereof selected from the group consisting of:
Assignments (4)
CHANGE OF NAME
Recorded Oct 27, 2016
From: NANTBIO, INC.
To: NANTBIOSCIENCE, INC.
Reel/Frame 040505/0295 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Apr 9, 2014
From: NANT HOLDINGS IP, LLC
To: NANTBIO, INC.
Reel/Frame 032635/0932 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Sep 18, 2013
From: ABRAXIS BIOSCIENCE, INC.; ABRAXIS BIOSCIENCE, LLC
To: CALIFORNIA CAPITAL EQUITY, LLC
Reel/Frame 031229/0697 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Sep 18, 2013
From: CALIFORNIA CAPITAL EQUITY, LLC
To: NANT HOLDINGS IP, LLC
Reel/Frame 031230/0335 →
Continuity (3)
Provisional Application
60875057
· Dec 15, 2006